Adial Pharmaceuticals, Inc. Accounts Payable and Accrued Liabilities
Adial Pharmaceuticals, Inc. (ADIL) had Accounts Payable and Accrued Liabilities of $776.95 thousand as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2019-11-14
- 2019-09-30: Accounts Payable and Accrued Liabilities $776.95K.
- 2018-12-31: Accounts Payable and Accrued Liabilities $257.97K.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2019-09-30 | $776.95K 10-Q · filed 2019-11-14 |
| 2018-12-31 | $257.97K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |